Navigation Links
Hybridoma Development,,, from QED Bioscience Inc.

ProductsHybridoma Development, from QED Bioscience Inc.
Company QED Bioscience Inc.
Item Hybridoma Development
Price 
Description QED Bioscience has over 23 years of experience in the development of hybridoma cells lines. We have made antibodies to large and small peptides, proteins, haptens, carbohydrates, bacterial and viral antigens, and plasmid DNA-encoded antigens. We understand and appreciate that every antigen is unique, so our hybridoma development programs are never "cookbook". We will tailor a program to your needs after we discuss important features of your antigens and the antibodies you require.

Features and Benefits:

  • Typical time frame for completion is 5-6 months.
  • Project tailored to the clients specific antibody needs.
  • Our programs are "modular", so you can choose how large or small you want each phase of your program to be.
  • Supernatant samples available to the client for testing in their system for subcloning selection.
  • Antibody is produced from 5 clones selected by the client; antibody from additional clones can be produced for a nominal cost.
  • All materials are the property of the client and are maintained until directed otherwise by the client.
  • Development is set up in phases. Billing is at the beginning of each phase, so if the project does not proceed to the subsequent phase, you are not billed.
PHASE I: IMMUNIZATION

1. Immunization of 5 Balb/c mice.
2. Initial rest period of 8 weeks to optimize for high titer IgG responses.
2. Test bleeds are evaluated by ELISA; bleeds are available to the client for testing.
3. The animals with the highest titers for selected for fusion.

Estimated completion time: 10-14 weeks ($1,845.00)

PHASE II: FUSION

1. Spleen cells from selected animals are fused with two different myeloma cell lines.
2. Remaining fusion cocktail is frozen for future use, if necessary.

Estimated completion time: 2-3 weeks ($3,690.00)

PHASE III: ANALYSIS

1. Antibody-positive parental hybridomas and subclones are evaluated by ELISA.
2. Supernatant fluid samples are available to the client for evaluation in their systems.
Up to 25 antibody-positive cultures will be carried through the subcloning and analysis phase.
5 clones may be selected for Antibody Production; antibody may be produced from additional clones for a nominal charge.

Estimated completion time: 6-8 weeks ($2,240.00)

PHASE IV: ANTIBODY PRODUCTION

1. Antibody is produced either in ascites (5 mice per clone) or in vitro (150 ml per clone).
2. Our proprietary in vitro medium produces 5-25 fold greater yields of antibody than conventional media.
3. All antibody production is done to cGMP standards.

Estimated completion time: 3-4 weeks ($1,150.00)

Total Estimated Completion Time: 5-6 months ($8,925.00)

GMP Ascites Production

QED offers complete programs for ascites production, from small R&D scale to pilot lot production to large-scale production. We are a USDA-registered research facility, and we comply with all federal guidelines for care and use of laboratory animals.

You may provide your hybridoma cell lines to QED either frozen or in culture. We will advise you on how many cells to send and how to ship your cells to us. Approximately one week is needed to prepare cells from frozen stocks for injection, and there is an additional charge for this service (see below).

Nude and SCID mice are available for ascites production for non-murine hybridoma cell lines.

Hybridomas are injected into pristane-primed mice, then mice are monitored daily for ascites development and general condition. Ascites collection begins when accumulation of ascites becomes evident and continues until final harvests are performed. If you choose, you can receive unpurified, defibrinated ascites, or QED will purify ascites for you (s

Info QED Bioscience Inc.QED Bioscience Inc.
QED Bioscience Inc.
11021 Via Frontera #203
San Diego, CA 92127
Customer Service: (800) 929-2114
Fax Number: (858) 592-1509
Web Site: http://www.qedbio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Mouse Anti-Xenopus laevis Xenopus nuclear factor Antibody, Unconjugated from Developmental Studies Hybridoma Bank
2. Hybridoma Storage from AbD Serotec
3. Mouse Anti-Drosophila Quail Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
4. Mouse Anti-Drosophila Yan Drosophila protein Antibody, Unconjugated from Developmental Studies Hybridoma Bank
5. Mouse Anti-Xenopus laevis Xenopus nuclear factor, xnf7 Antibody, Unconjugated from Developmental Studies Hybridoma Bank
6. Mouse Anti-Quail cell marker Antibody, Unconjugated from Developmental Studies Hybridoma Bank
7. Mouse Anti-Human VCAM-1 Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
8. Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
9. Mouse Anti-Drosophila fasciclin III Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
10. Hybridoma Development from Covance Research Products, Inc
11. Mouse Anti-Human huntingtin Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
... Kits overcome this limitation and offer high ... range in low-density protein array (96- and ... ideal for performing reverse-phase protein arrays and ... presence of low abundant antigens. Protein Detector ...
... for arraying proteins of interest with ... equipment. DiscoverLight Protein Array Kits allow ... cell lysate or antibody in a ... specially designed nitrocellulose membranes with a ...
Request Info...
... Conjugate Stabilizer is an aqueous solution ... and other non-toxic stabilizing chemicals in ... 5.5 6.5. This product ... and 0.02% bromonitrodioxane as a preservative. ...
Biology Products:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... Research and Markets has announced ... 2016-2020,"  report to their offering.  , ... global gait biometrics market is expected to grow ... 2016-2020. Gait analysis generates multiple variables ... to compute factors that are not or cannot ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
Breaking Biology Technology: